Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-02

Clinical Trial Update: BMI Effect on the Response to Ovulation Induction in Letrozole vs Clomid [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how body mass index influences response to ovulation induction with Letrozole versus Clomiphene (Clomid) in subfertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clomiphene (Clomid) (Clomiphene)
  • Letrozole (letrozole)

Snippet

Sponsor: Cairo University | Conditions: Subfertility | Phase 4 | Status: UNKNOWN